Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research Article
  • Published:

Codon 311 (Cys → Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias

Molecular Psychiatry volume 7, pages 110–112 (2002)Cite this article

Abstract

The gene of an esterase enzyme, called paraoxonase (PON, EC.3.1.8.1.) is a member of a multigene family that comprises three related genes PON1, PON2, and PON3 with structural homology clustering on the chromosome 7.1,2 The PON1 activity and the polymorphism of the PON1 and PON2 genes have been found to be associated with risk of cardiovascular diseases such as hypercholesterolaemia, non-insulin-dependent diabetes, coronary heart disease (CHD) and myocardial infaction.3–8 The importance of cardiovascular risk factors in the pathomechanism of Alzheimer's disease (AD) and vascular dementia (VD)9–13 prompted us to examine the genetic effect of PON2 gene codon 311 (Cys→Ser; PON2*S) polymorphism and the relationship between the PON2*S allele and the other dementia risk factor, the apoE polymorphism in these dementias. The PON2*C and PON2*S allele frequencies were similar in both AD (25% and 75%) and VD groups (23% and 77%), respectively, compared with the controls (27% and 73%). The ratio of the PON2*S carriers was significantly higher among the apoE4 allele carrier AD (27%) and VD (25%) groups than in the control (12%). Our results indicate that the PON2*S and apoE4 alleles have interactive effect on the development of the two most common forms of dementias AD and VD, and further support the hypothesis that cardiovascular factors contribute to the development of AD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Sorenson RC, Primo-Parmo SL, Camper SA, La Du BN . The genetic mapping and gene structure of mouse paraoxonase/arylesterase Genomics 1995 30: 431–438

    Article  CAS  Google Scholar 

  2. Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN . The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family Genomics 1996 382: 498–507

    Article  Google Scholar 

  3. McElween J, Mackness MI, Colley CM, Perad T, Warner S, Walker CH . Distribution of paraoxonase hydrolytic activity in the serum of patients after myocardial infarction Clin Chem 1986 32: 671–673

    Google Scholar 

  4. Mackness MI, Harty D, Bhatnagar D, Winocur PH, Arrol S, Ishola M et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus Atherosclerosis 1991 86: 193–199

    Article  CAS  Google Scholar 

  5. Abbott CA, Mackness MI, Kumar S, Boulton AJ, Durrington PN . Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins Arterioscler Thromb Vasc Biol 1995 15: 1812–1818

    Article  CAS  Google Scholar 

  6. Ruiz J, Blanche H, James RW, Garin MC, Vaisse C, Charpentier G et al. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes Lancet 1995 346: 869–872

    Article  CAS  Google Scholar 

  7. Garin MC, James RW, Dussoix P, Blanche H, Passa P, Froguel P et al. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes J Clin Invest 1997 99: 62–66

    Article  CAS  Google Scholar 

  8. Rice GI, Ossei-Gerning N, Stickland MH, Grant PJ . The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease Coronary Artery Disease 1997 8: 677–682

    Article  CAS  Google Scholar 

  9. De la Torre JC . Critical threshold cerebral hypoperfusion causes Alzheimer's disease? Acta Neuropathologica 1999 98: 1–8

    Article  CAS  Google Scholar 

  10. Sparks DL . Intraneuronal β-amyloid immunoreactivity in the CNS Neurobiol Aging 1995 17: 291–299

    Article  Google Scholar 

  11. Guo Z, Viitanen M, Fratiglioni L, Winblad B . Low blood pressure and dementia in elderly people: the Kungsholmen project Br Med J 1996 312: 805–808

    Article  CAS  Google Scholar 

  12. Kálmán J, Juhász A, Császár A, Kanka A, Maglóczky E, Bencsik K et al. Apolipoprotein E allele frequencies in patients with late onset sporadic Alzheimer's dementia in Hungary Acta Neurol Scand 1997 95: 56–59

    Article  Google Scholar 

  13. Kálmán J, Juhász A, Császár A, Kanka A, Rimanóczy Á, Janka Z et al. Increased apolipoprotein frequency is associated with vascular dementia in the Hungarian population Acta Neurol Scand 1998 98: 166–168

    Article  Google Scholar 

  14. Sanghera DK, Aston CE, Saha N, Kamboh MI . DNA polymorphism in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease Am J Hum Genet 1998 62: 36–44

    Article  CAS  Google Scholar 

  15. Antakainen M, Murtomaki S, Syvanne M, Pahlman R, Tahvanainen E, Jauhiainen M et al. The Gln-Arg 192 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of the coronary artery disease in Finns J Clin Invest 1996 98: 883–885

    Article  Google Scholar 

  16. Ombres D, Pannitteri G, Montali A, Candeloro A, Seccareccia F, Campagna F et al. The Gln-Arg 192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in Italian patients Arterioscler Thromb Vasc Biol 1998 18: 1611–1616

    Article  CAS  Google Scholar 

  17. Harding RM, Sokal RR . Classification of the European language families by genetic distance Proc Natl Acad Sci USA 1988 85: 9370–9372

    Article  CAS  Google Scholar 

  18. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Császár A et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations Am J Hum Genet 1991 49: 338–349

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN . Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase J Clin Invest 1998 101: 1581–1590

    Article  CAS  Google Scholar 

  20. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM et al. Protective effect of high density lipoprotein associated paraoxonase J Clin Invest 1995 96: 2882–2891

    Article  CAS  Google Scholar 

  21. Mackness B, Mackness MI, Arrol S, Turkie W, Julier K, Abuasha B et al. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus Atherosclerosis 1998 139: 341–349

    Article  CAS  Google Scholar 

  22. Kálmán J, Kudchodkar BJ, Murray K, McConathy WJ, Juhász A, Janka Z et al. Evaluation of serum-lipid related cardiovascular risk factors in Alzheimer's disease Dementia Geriatr Cogn Dis 1999 10: 488–493

    Article  Google Scholar 

  23. Sodeyama N, Yamada M, Itoh Y, Suematsu N, Matsushita M, Otomo E . No association of paraoxonase gene polymorphism with atherosclerosis or Alzheimer's disease Neurology 1999 53: 1146–1148

    Article  CAS  Google Scholar 

  24. Császár A, Kálmán J, Szalai Cs, Janka Z, Romics L . Association of the apolipoprotein A-IV codon 360 mutation in patients with Alzheimer's disease Neurosci Lett 1997 230: 1–4

    Article  Google Scholar 

  25. Miller SA, Dykes DD, Polesky HF . A simple salting out procedure for extracting DNA from human nucleated cells Nucl Acid Res 1988 16: 1215–1218

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors wish to thank all the probands who participated in the study. This work has been supported by a grant from the Health Scientific Board ETT 01817/2000, Hungary.

Author information

Authors and Affiliations

  1. Department of Psychiatry, Albert Szent-Györgyi Center for Medical and Pharmaceutical Sciences, Faculty of Medicine, University of Szeged, Semmelweis u. 6, Szeged, H-6725, Hungary

    Z Janka, A Juhász, Á Rimanóczy & J Kálmán

  2. Medical Informatics, Albert Szent-Györgyi Center for Medical and Pharmaceutical Sciences, Faculty of Medicine, University of Szeged, Semmelweis u. 6, Szeged, H-6725, Hungary

    K Boda

  3. Central Laboratory, Békés County Hospital, PO Box 46, Gyula, H-5701, Hungary

    J Márki-Zay

Authors
  1. Z Janka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Juhász
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Á Rimanóczy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K Boda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Márki-Zay
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Kálmán
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Kálmán.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janka, Z., Juhász, A., Rimanóczy, Á. et al. Codon 311 (Cys → Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias. Mol Psychiatry 7, 110–112 (2002). https://doi.org/10.1038/sj.mp.4000916

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4000916

Keywords

Search

Advanced search

Quick links